Method Article

A Unified Methodological Framework for Vestibular Schwannoma Research

7.3K views

DOI:

10.3791/55827

June 20th, 2017

* These authors contributed equally

In This Article

Summary

The goal of this protocol is to outline the collection and processing of human surgical samples for multiple downstream applications in vestibular schwannoma and Schwann cell research.

Abstract

Vestibular schwannomas are the most common neoplasms of the cerebellopontine angle, making up 6-8% percent of all intracranial growths. Though these tumors cause sensorineural hearing loss in up to 95% of affected individuals, the molecular mechanisms underlying this hearing loss remain elusive. This article outlines the steps established in our laboratory to facilitate the collection and processing of various primary human tissue samples for downstream research applications integral to the study of vestibular schwannomas. Specifically, this work describes a unified methodological framework for the collection, processing, and culture of Schwann and schwannoma cells from surgical samples. This is integrated with parallel processing steps now considered essential for current research: the collection of tumor and nerve secretions, the preservation of RNA and the extraction of protein from collected tissues, the fixation of tissue for the preparation of sections, and the exposure of primary human cells to adeno-associated viruses for application to gene therapy. Additionally, this work highlights the translabyrinthine surgical approach to collect this tumor as a unique opportunity to obtain human sensory epithelium from the inner ear and perilymph. Tips to improve experimental quality are provided and common pitfalls highlighted.

Introduction

Vestibular schwannomas (VSs) are the most common neoplasms of the cerebellopontine angle, diagnosed in 1 in every 100,000 individuals. Though non-metastatic, these tumors severely affect a patient's quality of life1,2,3,4,5,6. Affected individuals commonly live with hearing loss, tinnitus, and a feeling of aural fullness. Symptoms become increasingly debilitating as the tumor grows, causing balance problems, facial paralysis, and impairment of other cranial nerve funct....

Access restricted. Please log in or start a trial to view this content.

Protocol

Written informed consent for the collection of all samples was obtained prior to surgery, and the experiments were carried out according to the Code of Ethics of the World Medical Association (Declaration of Helsinki). All sections of the study protocol were approved by the Institutional Review Board of Massachusetts Eye and Ear and Massachusetts General Hospital.

NOTE: Sections 1-7 below are designed to be performed sequentially upon the receipt of a primary human VS or GAN sample from the operating room. Processing should always begin with section 1. Then, as a rule, RNA should be preserved first (section 2), followed by the preparation o....

Access restricted. Please log in or start a trial to view this content.

Results

Primary human VS cells in culture, as established in section 5, can be treated as informative models for disease-associated processes in many downstream research applications (Figure 1). Healthy Schwann cells cultured in section 6 provide a direct and instructive point of comparison. As outlined below, extensive data from VSs and GANs processed according to this unified methodological framework are available in multiple articles previously published

Access restricted. Please log in or start a trial to view this content.

Discussion

This manuscript describes a unified methodological framework for VS research, outlining the simultaneous processing of human VS and GAN specimens for downstream research applications. As VS research enters the age of precision medicine, preparing the same sample in forms capable of answering numerous research questions will enable the discovery of molecular, cellular, genetic, and proteomic insights specific to individual patients.

The purity of human Schwann cell and VS cultures were thorough.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by the National Institute of Deafness and Other Communication Disorders grants R01DC015824 (K.M.S.) and T32DC00038 (supporting J.E.S and S.D.), the Department of Defense grant W81XWH-14-1-0091 (K.M.S.), the Bertarelli Foundation (K.M.S.), the Nancy Sayles Day Foundation (K.M.S.), the Lauer Tinnitus Research Center (K.M.S.), and the Barnes Foundation (K.M.S.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
BioCoat Poly-D-Lysine/Laminin 12 mm #1 German Glass CoverslipCorning354087Or prepare coverslips with Corning Laminin (CB-40232) and Cultrex Poly-L-Lysine (3438-100-01)
CELLSTAR 15 mL Centrifuge Tubes, Conical bottom, Graduation, SterileGreiner Bio-One188161
CELLSTAR 50 mL Centrifuge Tubes, Conical bottom, Graduation, SterileGreiner Bio-One227261
CELLSTAR Cell Culture Dish, 60 mmGreiner Bio-One628160
Collagenase from Clostridium histolyticum, Sterile-filteredSigma-AldrichC1639
Costar 24 Well Clear TC-Treated Multiple Well Plates, SterileCorning3526
DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride)Thermo Fisher ScientificD1306
DMEM, high glucose, pyruvate, no glutamine, 500 mLThermo Fisher Scientific10313-039
DMEM/F-12, 500 mLThermo Fisher Scientific11320-033
Dumont #3 Forceps, DumoxelFine Science Tools11231-30Autoclave prior to use
Dumont #5 Forceps, Standard tip, InoxFine Science Tools11251-20Autoclave prior to use
Fetal Bovine Serum, qualified, USDA-approved regions, 500 mLThermo Fisher Scientific10437-028Aliquot in 50 mL tubes and store in -20°C freezer
Hyaluronidase from Bovine Testes, Type I-S, Lyophilized PowderSigma-AldrichH3506
Millex-GP Syringe Filter Unit, 0.22 µm, polyethersulfone, 33 mm, sterileEMD MilliporeSLGP033RS
Paraformaldehyde, Reagent Grade, CrystallineSigma-AldrichP6148Prior to use: Establish Standard Operating Procedures based on protocols available online
PBS, pH 7.4, 500 mLThermo Fisher Scientific10010-023Autoclave prior to use
Penicillin-Streptomycin (10,000 U/mL), 100 mLThermo Fisher Scientific15140-122
PhosSTOP Phosphatase Inhibitor TabletsRoche04906845001
Pierce Protease Inhibitor TabletsThermo Fisher Scientific88666
Pipettes and pipette tips, 5/10/25 mLVariableVariable
Plastic Homogenization Pestle for 1.5/2.0 mL MicrotubesE&K ScientificEK-10539
PrecisionGlide Needles, 27 G x 1 1/2 inBD301629
RIPA BufferBoston BioProductsBP-115
RNAlater (RNA stabilization solution)Thermo Fisher ScientificAM7021
Safe-Lock Microcentrifuge Tubes, Polypropylene, 0.5 mLEppendorf022363719Autoclave prior to use
Safe-Lock Microcentrifuge Tubes, Polypropylene, 1.5 mLEppendorf022363204Autoclave prior to use
Saline - 0.9% Sodium Chloride Injection, bacteriostatic, 20 mLHospira0409-1966-05
Scalpel Blades - #15Fine Science Tools10015-00
Schuknecht Suction Tube 24 gaugeBausch + LombN1698 42Useful for the surgical approach (in addition to common otologic surgical instruments) and e.g. a blue surgical marker
Specimen Container, OR sterile, 4OZMedlineDYND30331H
Stemi 2000-C Stereo MicroscopeZeiss000000-1106-133
Syringe/Needle Combination, Luer-Lok Tip, 5 mL, 22 G x 1 in.BD309630
Tuberculin Syringe Only, Slip tip, 1 mLBD309659
Tuberculin Syringe Only, Slip tip, 3 mLBD309656
Ultrasonic homogenizer, 4710 Series, CV18 probeCole-ParmerCP25013

References

  1. Babu, R., et al. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg. 119 (1), 121-130 (2013).
  2. Gal, T. J., Shinn, J., Huang, B. Current epidemiology and manage....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Schwann CellsPrimary Cell CultureTumor Secretion CollectionRNA PreservationProtein ExtractionTissue FixationAdeno Associated VirusTranslabyrinthine ApproachCell Culture Protocol

Related Articles